Perception of Psychosocial Burden in Mothers of Children with Rare Pediatric Neurological Diseases

Overview

Journal Sci Rep

Specialty Science

Date 2025 Feb 21

PMID 39984547

Authors

Dariusz Walkowiak

Jan Domaradzki

Affiliations

Soon will be listed here.

Abstract

Parenting a child with rare paediatric neurological diseases (RPNDs) severely affects parents' quality of life and the caregiver burden. Since mothers tend to be the primary caregivers more often, this study focuses on previously unexplored experiences of mothers of four RPNDs: 22q11.2 deletion syndrome (22q11.2DS), Angelman syndrome (AS), Dravet syndrome (DS) and Williams syndrome (WS). A cross-sectional survey of 302 mothers revealed that, while caring for RPND children seriously impacts well-being and stress in all mothers, there also exist some significant differences in diagnostic experiences, quality of life and the caregiver burden across conditions. DS and AS mothers reported difficulties in the access to and reimbursement for modern genetic testing and psychological support. DS and WS mothers were concerned over the impact of the delayed diagnosis on unnecessary hospitalisations and medication in their children. 22q11.2DS mothers felt more supported than others. While DS and AS mothers reported a greater burden in caregiving and reduced quality of life, WS mothers reported significantly lower burdens and higher scores across all quality-of-life domains. Mothers' financial well-being, employment status and early diagnosis significantly influenced their experiences. These findings underscore the need for tailored support for RPND mothers, with a focus on early diagnosis and financial and psychological help.

References

Suleja A, Milska-Musa K, Przyslo L, Bednarczyk M, Kostecki M, Cysewski D . Angelman syndrome in Poland: current diagnosis and therapy status-the caregiver perspective: a questionnaire study. Orphanet J Rare Dis. 2024; 19(1):306. PMC: 11340045. DOI: 10.1186/s13023-024-03292-w. View

Duis J, Nespeca M, Summers J, Bird L, Bindels-de Heus K, Valstar M . A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome. Mol Genet Genomic Med. 2022; 10(3):e1843. PMC: 8922964. DOI: 10.1002/mgg3.1843. View

Chiarotti F, Kodra Y, De Santis M, Bellenghi M, Taruscio D, Care A . Gender and burden differences in family caregivers of patients affected by ten rare diseases. Ann Ist Super Sanita. 2023; 59(2):122-131. DOI: 10.4415/ANN_23_02_05. View

Gao C, Pielas M, Jiao F, Mei D, Wang X, Kotulska K . Epilepsy in Dravet Syndrome-Current and Future Therapeutic Opportunities. J Clin Med. 2023; 12(7). PMC: 10094968. DOI: 10.3390/jcm12072532. View

Giussani G, Falcicchio G, La Neve A, Costagliola G, Striano P, Scarabello A . Sudden unexpected death in epilepsy: A critical view of the literature. Epilepsia Open. 2023; 8(3):728-757. PMC: 10472423. DOI: 10.1002/epi4.12722. View

Morris C . The behavioral phenotype of Williams syndrome: A recognizable pattern of neurodevelopment. Am J Med Genet C Semin Med Genet. 2010; 154C(4):427-31. DOI: 10.1002/ajmg.c.30286. View

McMullan J, Lohfeld L, McKnight A . Needs of informal caregivers of people with a rare disease: a rapid review of the literature. BMJ Open. 2022; 12(12):e063263. PMC: 9748923. DOI: 10.1136/bmjopen-2022-063263. View

Domaradzki J, Walkowiak D . Invisible patients in rare diseases: parental experiences with the healthcare and social services for children with rare diseases. A mixed method study. Sci Rep. 2024; 14(1):14016. PMC: 11189503. DOI: 10.1038/s41598-024-63962-4. View

Di Resta C, Pipitone G, Carrera P, Ferrari M . Current scenario of the genetic testing for rare neurological disorders exploiting next generation sequencing. Neural Regen Res. 2020; 16(3):475-481. PMC: 7996035. DOI: 10.4103/1673-5374.293135. View

10.

The Lancet Neurology . Rare diseases: maintaining momentum. Lancet Neurol. 2022; 21(3):203. DOI: 10.1016/S1474-4422(22)00046-1. View

11.

Chu S, Wen C, Weng C . Gender Differences in Caring for Children with Genetic or Rare Diseases: A Mixed-Methods Study. Children (Basel). 2022; 9(5). PMC: 9139271. DOI: 10.3390/children9050627. View

12.

Cardinali P, Migliorini L, Rania N . The Caregiving Experiences of Fathers and Mothers of Children With Rare Diseases in Italy: Challenges and Social Support Perceptions. Front Psychol. 2019; 10:1780. PMC: 6690318. DOI: 10.3389/fpsyg.2019.01780. View

13.

Matilla-Duenas A, Corral-Juan M, Seuma A, Vilas D, Ispierto L, Morais S . Rare Neurodegenerative Diseases: Clinical and Genetic Update. Adv Exp Med Biol. 2017; 1031:443-496. DOI: 10.1007/978-3-319-67144-4_25. View

14.

Williams C, Driscoll D, Dagli A . Clinical and genetic aspects of Angelman syndrome. Genet Med. 2010; 12(7):385-95. DOI: 10.1097/GIM.0b013e3181def138. View

15.

Sadhwani A, Willen J, LaVallee N, Stepanians M, Miller H, Peters S . Maladaptive behaviors in individuals with Angelman syndrome. Am J Med Genet A. 2019; 179(6):983-992. PMC: 8407596. DOI: 10.1002/ajmg.a.61140. View

16.

Manalel J, Sumrall S, Davidson H, Grewal M, Granovetter M, Koehly L . Stress, coping, and positive aspects of caregiving among caregivers of children with rare disease. Psychol Health. 2022; 39(2):216-232. PMC: 9701241. DOI: 10.1080/08870446.2022.2057494. View

17.

Goodwin J, McCormack L, Campbell L . "You don't know until you get there": The positive and negative "lived" experience of parenting an adult child with 22q11.2 deletion syndrome. Health Psychol. 2016; 36(1):45-54. DOI: 10.1037/hea0000415. View

18.

Domaradzki J, Walkowiak D . Ultra-rare ultra-care: Assessing the impact of caring for children with ultra rare diseases. Eur J Paediatr Neurol. 2023; 48:78-84. DOI: 10.1016/j.ejpn.2023.12.003. View

19.

Rihm L, Dreier M, Rezvani F, Wiegand-Grefe S, Dirmaier J . The psychosocial situation of families caring for children with rare diseases during the COVID-19 pandemic: results of a cross-sectional online survey. Orphanet J Rare Dis. 2022; 17(1):449. PMC: 9791975. DOI: 10.1186/s13023-022-02595-0. View

20.

Yang G, Cintina I, Pariser A, Oehrlein E, Sullivan J, Kennedy A . The national economic burden of rare disease in the United States in 2019. Orphanet J Rare Dis. 2022; 17(1):163. PMC: 9004040. DOI: 10.1186/s13023-022-02299-5. View